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Letter to the Editor
Imatinib-induced long-term remission in a relapsed
Including the patient described herein, ten cases with B-cell precursor ALL and a molecular genetically verified RCSD1-ABL1 fusion gene have been reported so far (Table 1) . [4] [5] [6] 8, [10] [11] [12] [13] [14] An identical translocation was also found in an ABL1-positive biphenotypic ALL case in which, however, the partner gene has not been ascertained. 15 Four of these patients were treated with TKIs and all of them achieved at least a partial remission (Table 1) . 6, 10, 13, 14 To the best of our knowledge, time-wise and formally, however, our patient is not only the first RCSD1-ABL-positive case, but also the overall first one with a variant ABL1 fusion, who was rescued with imatinib treatment and cured despite cessation of therapy.
Our instructive case underscores the importance of identifying these particular genetic lesions, as they may become highly relevant for appropriate treatment 
